Clinical Trials
41 trialsPhase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
FLT-MM
Ankara University
PITHAC
Centre Hospitalier Universitaire Vaudois
SCITH-MESO
Hospices Civils de Lyon
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
RS Oncology LLC
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
PROSPECT
University of Oxford
MiST
University of Leicester
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
REGOMUNE
Institut Bergonié
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
European Organisation for Research and Treatment of Cancer - EORTC
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
ImmVira Pharma Co. Ltd
Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma
Ain Shams University
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Momotaro-Gene Inc.
VATS
Ain Shams University
Real World Study of MPM in China
ChineseAMS
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China
TALAMESO
Hospices Civils de Lyon
PIPACRegis
University of Magdeburg
IP3R Modulation by Cancer Genes in Mesothelioma
KU Leuven
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Confocal Laser Endomicroscopy in Pleural Malignancies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Rigshospitalet, Denmark
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Italian Network for Tumor Biotherapy Foundation
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Response Evaluation in Malignant Pleural Mesothelioma
Istituto Clinico Humanitas
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
Ain Shams University
ADAM
Barts & The London NHS Trust
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
National Cancer Institute (NCI)
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
National Cancer Institute (NCI)
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
National Cancer Institute (NCI)
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Trimodality Therapy for Malignant Pleural Mesothelioma
HSK Wiesbaden
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
National Cancer Institute (NCI)
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
National Cancer Institute (NCI)
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
National Institute of Cancerología